Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics integration and interactomics reveals molecular networks and regulators of the beneficial effect of yoga and exercise. | Int J Yoga | 2022 | 35444372 | PubTator, text mining | PubMed |
| Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy. | Front Oncol | 2022 | 35433470 | PubTator, text mining | PubMed |
| Swine Enteric Coronavirus: Diverse Pathogen-Host Interactions. | Int J Mol Sci | 2022 | 35409315 | PubTator, text mining | PubMed |
| Immune Checkpoint Receptors Signaling in T Cells. | Int J Mol Sci | 2022 | 35408889 | PubTator, text mining | PubMed |
| Immunomodulatory Properties of Immune Checkpoint Inhibitors-More than Boosting T-Cell Responses? | Cancers (Basel) | 2022 | 35406483 | PubTator, text mining | PubMed |
| A Selective β-Catenin-Metadherin/CEACAM1-CCL3 Axis Mediates Metastatic Heterogeneity upon Tumor-Macrophage Interaction. | Adv Sci (Weinh) | 2022 | 35403834 | PubTator, text mining | PubMed |
| Junctional epithelium and hemidesmosomes: Tape and rivets for solving the "percutaneous device dilemma" in dental and other permanent implants. | Bioact Mater | 2022 | 35387164 | PubTator, text mining | PubMed |
| Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro. | Chin Med | 2022 | 35365215 | PubTator, text mining | PubMed |
| Overexpression of CEACAM6 activates Src-FAK signaling and inhibits anoikis, through homophilic interactions in lung adenocarcinomas. | Transl Oncol | 2022 | 35358791 | PubTator, text mining | PubMed |
| Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. | Cell Death Dis | 2022 | 35354793 | PubTator, text mining | PubMed |
| Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer. | Cell Commun Signal | 2022 | 35346234 | PubTator, text mining | PubMed |
| Variable Expression of Opa Proteins by Neisseria gonorrhoeae Influences Bacterial Association and Phagocytic Killing by Human Neutrophils. | J Bacteriol | 2022 | 35343795 | PubTator, text mining | PubMed |
| Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment. | J Immunol Res | 2022 | 35340585 | PubTator, text mining | PubMed |
| The Interplay between Tumour Microenvironment Components in Malignant Melanoma. | Medicina (Kaunas) | 2022 | 35334544 | PubTator, text mining | PubMed |
| Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules? | Int J Mol Sci | 2022 | 35328510 | PubTator, text mining | PubMed |
| 1α,25(OH)2D3 reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells. | J Immunother Cancer | 2022 | 35318258 | PubTator, text mining | PubMed |
| Tim-3 mediates T cell trogocytosis to limit antitumor immunity. | J Clin Invest | 2022 | 35316223 | PubTator, text mining | PubMed |
| Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer. | Cancer Immunol Immunother | 2022 | 35301576 | PubTator, text mining | PubMed |
| A low n-6 to n-3 polyunsaturated fatty acid ratio diet improves hyperinsulinaemia by restoring insulin clearance in obese youth. | Diabetes Obes Metab | 2022 | 35297549 | PubTator, text mining | PubMed |
| CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells. | Blood Adv | 2022 | 35286394 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=41